HTFL MEXC RealStocks
Own real HTFL shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 15:35:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Heartflow, Inc. (HTFL) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $58.34, with a market capitalization of $4.85B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $20.13 to $60.66. This page covers its latest market performance, valuation, price trends and company information.
$4.85B | |
$58.28 | |
$59.67 | |
$57.60 | |
$59.10 | |
1.01M | |
2.03M | |
-- | |
$60.66 | |
$20.13 | |
-- | |
-- |
Heartflow, Inc. (HTFL) is currently trading at $58.34 as of 2026-11-12 15:33:00, down 0.41% ($0.24) from the previous close of $59.10
During today's regular trading session, HTFL has traded between $57.60 and $59.67, with a trading volume of 1.01M shares. The current price is near the middle of today's range.
Over the past seven days, Heartflow, Inc. (HTFL) moved from $54.40 to $58.34, representing a gain of 7.24% ($3.94).
The stock traded between $51.06 and $60.66 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.60 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 94.3%
HTFL is currently trading at $58.34, placing it 94.3% of the way from its 52-week low of $20.13 to its 52-week high of $60.66. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 843 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Heartflow, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Heartflow, Inc. (HTFL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to HTFL, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between HTFL shares and USD.
HTFL Shares to USD
1.00 HTFL shares = 58.339 USD
Calculations are estimates based on the latest available price and are for reference only.